MEIP - MEI Pharma GAAP EPS of $0.08 beats by $0.29 revenue of $32.74M beats by $29.4M February, 09 2023 04:52 PM MEI Pharma Inc. MEI Pharma press release ( NASDAQ: MEIP ): Q2 GAAP EPS of $0.08 beats by $0.29 . Revenue of $32.74M (+79.7% Y/Y) beats by $29.4M . For further details see: MEI Pharma GAAP EPS of $0.08 beats by $0.29, revenue of $32.74M beats by $29.4M